Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03811808 · ClinicalTrials.gov registry record
Multiple System Atrophy Multidisciplinary Clinic
A clinical trial of Multiple System Atrophy (MSA), sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03811808: Recruiting study of Multiple System Atrophy (MSA), sponsored by University of Texas Southwestern Medical Center.
NCT03811808 is a study of Multiple System Atrophy (MSA) that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03811808, a study of Multiple System Atrophy (MSA), is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective cohort study to examine the disease burden of multiple system atrophy and the impact of multidisciplinary care on quality of life and caregiver burden. Data will be collected through valid rating scales completed by patients and caregivers at home or in the MSA clinic.
Primary Outcome
The disease burden of MSA and impact of multidisciplinary care on the quality of life of patients as measured by the MSA-Quality of Life (QOL) questionnaire completed every four months by the patients. The scale measures how MSA affects a person's quality of life in day to day activities. The scale ranges from No problem to Extreme Problem. The More Extreme Problem sections selected the more their quality of life is affected by the disease.
Conditions Studied
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-03 |
| Est. Completion | 2028-03 |
What NCT03811808 shows while recruiting
NCT03811808 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Multiple System Atrophy (MSA) appearing as the primary indexed condition, and to 0 interventions.
NCT03811808 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03811808 about?
NCT03811808 is a clinical study titled "Multiple System Atrophy Multidisciplinary Clinic". This is a prospective cohort study to examine the disease burden of multiple system atrophy and the impact of multidisciplinary care on quality of life and caregiver burden. Data will be collected through valid rating scales completed by patients and caregivers at home or in the MSA clinic.
What is the current status of trial NCT03811808?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2016-03. Estimated completion is 2028-03.
What conditions does trial NCT03811808 study?
This clinical trial studies the following conditions: Multiple System Atrophy (MSA).
Who is sponsoring clinical trial NCT03811808?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03811808 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple System Atrophy (MSA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia